RxDoctor Payments Data

Nandini Nair, MD

Advanced Heart Failure and Transplant Cardiology · Hershey, PANPI 1083875181

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,005 of the $2,374 with a category attached, or 84.5%. 9 manufacturers reported payments, led by Abiomed at 45.2% of the total. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in PA, where the typical reported total is $4,440.

$2,374in general payments, 2019–2025

Across 32 payments — averaging $74.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$1K
  • Abbott$886
  • Heartflow, Inc.$120
  • Alnylam Pharmaceuticals Inc.$97
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$84
  • Johnson & Johnson$39
  • plus $74 from 3 others
$26,481in research payments, 2019–2025

Across 13 payments — averaging $2037.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$19K
  • Amgen$8K

What the payments were for

  • Travel & lodging$36916%
  • Food & beverage$2,00584%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,374 in reported general payments places this provider in the 30th percentile of 96 advanced heart failure and transplant cardiology providers in Pennsylvania.

See all advanced heart failure and transplant cardiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$35,600
Medicare patients
141
Services billed
491

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan79$82,938
JardianceEmpagliflozin17$23,923
EliquisApixaban23$19,684
FarxigaDapagliflozin Propanediol11$10,924
DiurilChlorothiazide20$809
Potassium Chloride16$700
Metoprolol Succinate37$575
Bumetanide20$504
Torsemide15$381
Carvedilol34$354
Spironolactone36$319
Atorvastatin Calcium21$188
Furosemide71$170
Amlodipine Besylate27$83
Hydrochlorothiazide16$33

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Hershey

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →